News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Kim Mina
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/11/2023 |
4
| Kim Mina (Chief Legal & Admin. Officer) has filed a Form 4 on ACELYRIN, Inc.
Txns:
| Bought 5,000 shares
@ $18, valued at
$90k
Disposed of 362,719 options to buy
@ $5.8766, valued at
$2.1M
Acquired 362,719 options to buy
@ $5.8766, valued at
$2.1M
Disposed of 85,226 options to buy
@ $18, valued at
$1.5M
Acquired 85,226 options to buy
@ $18, valued at
$1.5M
|
|
05/04/2023 |
4
| Kim Mina (Chief Legal & Admin. Officer) has filed a Form 4 on ACELYRIN, Inc.
Txns:
| Granted 85,226 options to buy
@ $18, valued at
$1.5M
|
|
09/07/2022 |
4
| Kim Mina (Chief Legal Officer) has filed a Form 4 on Zymergen Inc.
Txns:
| Sold 3,410 shares
@ $2.21, valued at
$7.5k
|
|
08/04/2022 |
4
| Kim Mina (Chief Legal Officer) has filed a Form 4 on Zymergen Inc.
Txns:
| Sold 3,094 shares
@ $2.6125, valued at
$8.1k
|
|
07/07/2022 |
4
| Kim Mina (Chief Legal Officer) has filed a Form 4 on Zymergen Inc.
Txns:
| Sold 2,924 shares
@ $1.3223, valued at
$3.9k
|
|
06/06/2022 |
4
| Kim Mina (Chief Legal Officer) has filed a Form 4 on Zymergen Inc.
Txns:
| Sold 2,939 shares
@ $1.6776, valued at
$4.9k
|
|
05/04/2022 |
4
| Kim Mina (Chief Legal Officer) has filed a Form 4 on Zymergen Inc.
Txns:
| Sold 3,206 shares
@ $1.7903, valued at
$5.7k
|
|
03/15/2022 |
4
| Kim Mina (Chief Legal Officer) has filed a Form 4 on Zymergen Inc.
Txns:
| Granted 217,000 shares
@ $0 |
|
10/28/2021 |
4
| Kim Mina (Chief Legal Officer) has filed a Form 4 on Zymergen Inc.
Txns:
| Granted 97,000 shares
@ $0 Granted 194,000 options
@ $10, valued at
$1.9M
|
|
04/10/2019 |
4
| Kim Mina (Senior VP & General Counsel) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Paid exercise price by delivering 3,674 shares
@ $36.85, valued at
$135.4k
|
|
03/27/2019 |
4
| Kim Mina (Senior VP & General Counsel) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Granted 10,000 shares
@ $0 |
|
02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/09/2018 |
4
| Kim Mina (Senior VP & General Counsel) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Granted 42,500 shares
@ $0 Granted 70,000 options to buy
@ $36, valued at
$2.5M
|
|
03/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/10/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|